ABTD Stock Price and Chart — BCBA:ABTD

Overview

Financials News Ideas Discussions Technicals Seasonals Bonds

ABTD chart

Key facts today

Abbott Laboratories faces over 500 lawsuits regarding its cow milk-based formulas, including Similac, for allegedly failing to warn about the risk of necrotizing enterocolitis in premature infants.

Abbott Laboratories is set to release its quarterly financial results later this week, coinciding with earnings reports from major companies including Johnson & Johnson and PepsiCo.

Analyze the impact Analyze the impact

About Abbott Laboratories

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the line of branded generic pharmaceuticals manufactured worldwide and marketed and sold outside the United States in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternate care testing sites. The Nutritional Products segment caters to the worldwide sales of pediatric and adult nutritional products. The Medical Devices segment includes a broad line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care and continuous glucose monitoring products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.